News

Revolution Medicines, Summit Therapeutics Partner on RAS Inhibitor/Ivonescimab Combinations for Solid Tumors
Revolution Medicines Inc. (NASDAQ:RVMD) is one of the best high short interest stocks with huge upside potential. On June 30, ...
Summit Therapeutics Reportedly Makes $15B AstraZeneca Licensing Talks for Lung Cancer Drug
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best hot stocks to buy according to Wall Street analysts.
Deutsche Bank Says PepsiCo (PEP) Needs to Win Investor Confidence
PepsiCo, Inc. (NASDAQ:PEP) is one of the 10 Best Dip Stocks to Buy According to Billionaires. On June 27, Deutsche Bank ...